Regulon

Regulon: R-2124

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
17-0.33923910Pr-145Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
54 ENSG00000102575 ACP5 P13686
2444 ENSG00000111816 FRK P42685
79669 ENSG00000114529 C3orf52 Q5BVD1
5357 ENSG00000120756 PLS1 Q14651
23682 ENSG00000123892 RAB38 P57729
26298 ENSG00000135373 EHF Q9NZC4
2886 ENSG00000141738 GRB7 Q14451
1805 ENSG00000143196 DPT Q07507
3772 ENSG00000157551 KCNJ15 Q99712
4681 ENSG00000158747 NBL1 P41271
2810 ENSG00000175793 SFN P31947
1366 ENSG00000181885 CLDN7 O95471
11187 ENSG00000184363 PKP3 Q9Y446
54834 ENSG00000196505 GDAP2 Q9NXN4
4311 ENSG00000196549 MME P08473
57089 ENSG00000198018 ENTPD7 Q9NQZ7
90861 ENSG00000206053 HN1L Q9H910

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
DASATINIBABL1Small moleculeINHIBITORPlatelet-derived growth factor receptor beta inhibitor42
SACUBITRILMMESmall moleculeINHIBITORNeprilysin inhibitor40
ILEPATRILMMESmall moleculeINHIBITORAngiotensin-converting enzyme inhibitor20
ILORASERTIBPDGFRBSmall moleculeINHIBITORSerine/threonine-protein kinase Aurora inhibitor20
XL-228ABL1Small moleculeINHIBITORTyrosine-protein kinase ABL inhibitor10
TG100-801EPHB4Small moleculeINHIBITORSRC inhibitor20
DAGLUTRILMMESmall moleculeINHIBITOREndothelin-converting enzyme 1 inhibitor20
REGORAFENIBKDRSmall moleculeINHIBITORTyrosine-protein kinase TIE-2 inhibitor42
ENMD-981693PDGFRBSmall moleculeINHIBITORPlatelet-derived growth factor receptor inhibitor20

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2124

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs